SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (ME), a leading human genetics company, today announced the launch of Discover23®, a new research offering enabling ...

23andMe offers reports, among which are those based on statistical models known as polygenic scores (PRS). The PRS reports are developed by 23andMe scientists and clinical experts using the company’s ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. Bay Area-based 23andMe ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. San Francisco-based 23andMe ...

NEW YORK — New York Attorney General Letitia James issued a consumer alert to customers of 23andMe, a direct-to-consumer genetic testing company, urging them to take action to protect their data.

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase ...

The immigrant aid group Refugee and Immigrant Center for Education and Legal Services has turned down 23andMe’s offer to donate DNA kits to help reunite families separated at the U.S.-Mexico border as ...

23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their care SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. The Sunnyvale, Calif.-based ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...